Ishita Drugs and Industries Limited (ISHITADR.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-33.0%

₹48.27

vs ₹72.00 price

Levered DCF

₹12.94

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

—

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	27.17×	28.53×	27.2×	25.61×	15.37×	10.83×	5.98×	12.42×
P/B	1.83×	2.28×	2.05×	1.61×	1.44×	1.15×	0.47×	0.68×
P/S	1.44×	1.64×	1.34×	1.22×	0.88×	0.64×	0.22×	0.48×
EV / EBITDA	14.96×	20.9×	15.59×	15.73×	8.67×	5.89×	3.47×	6.38×
Gross margin	19.6%	19.1%	17.0%	25.5%	24.0%	21.8%	12.2%	14.1%
Operating margin	4.5%	5.9%	5.2%	5.2%	6.8%	5.5%	3.9%	4.0%
Net margin	5.3%	5.8%	4.9%	4.8%	5.7%	5.9%	3.7%	3.9%
Current ratio	9.65×	2.77×	11.14×	4.6×	3.82×	5.58×	3.27×	3.91×
Debt / equity	0.01×	0.36×	0×	0.1×	0×	0.01×	0.04×	0.03×
Interest coverage	11.25×	12.35×	8.87×	11.81×	39.1×	24.4×	16.88×	5.94×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	6.7%	8.0%	7.5%	6.3%	9.4%	10.6%	7.9%	5.5%
Return on invested capital	4.1%	4.6%	6.1%	4.6%	8.6%	7.7%	6.2%	4.1%
Return on assets	6.2%	5.3%	6.9%	5.1%	7.2%	9.0%	5.7%	4.2%
Free cash flow yield	11.6%	-15.5%	10.3%	-20.5%	24.7%	-7.6%	31.5%	11.9%
Earnings yield	3.7%	3.5%	3.7%	3.9%	6.5%	9.2%	16.7%	8.0%
Enterprise value	₹185.3M	₹279.5M	₹185.3M	₹151.3M	₹103.8M	₹72.6M	₹31.6M	₹42.6M
Net debt / EBITDA	-2.12×	2.49×	-1.54×	0.37×	-1.66×	-1.39×	-0.12×	-0.18×
Cash conversion cycle (days)	56	158	34	91	-21	38	-1	18